JAMA · 2022
Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement.
СтатьяСистематический обзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
US Preventive Services Task Force, Mangione Carol M, Barry Michael J, Nicholson Wanda K, Cabana Michael, Chelmow David, Coker Tumaini Rucker, Davis Esa M, Donahue Katrina E, Epling John W, Jaén Carlos Roberto, Krist Alex H, Kubik Martha, Li Li, Ogedegbe Gbenga, Pbert Lori, Ruiz John M, Simon Melissa A, Stevermer James, Wong John B
Аннотация
IMPORTANCE: Glaucoma affects an estimated 2.7 million people in the US. It is the second-leading cause of irreversible blindness in the US and the leading cause of blindness in Black and Hispanic/Latino persons.
OBJECTIVE: To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for glaucoma in adults.
POPULATION: Adults 40 years or older who present in primary care and do not have signs or symptoms of open-angle glaucoma.
EVIDENCE ASSESSMENT: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for glaucoma in adults. The benefits and harms of screening for glaucoma in adults are uncertain. More research is needed.
RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement).
OBJECTIVE: To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for glaucoma in adults.
POPULATION: Adults 40 years or older who present in primary care and do not have signs or symptoms of open-angle glaucoma.
EVIDENCE ASSESSMENT: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for glaucoma in adults. The benefits and harms of screening for glaucoma in adults are uncertain. More research is needed.
RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement).